Article Text
DTB commentary
What does the TIME study tell us about morning and evening dosing of antihypertensive medication?
Abstract
Commentary on: Mackenzie IS, Rogers A, Poulter NR, et al. Cardiovascular outcomes in adults with hypertension with evening vs morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet. 2022;400:1417–25.
- Drug-Related Side Effects and Adverse Reactions
- Health Care Quality, Access, and Evaluation